Liquid Levodopa/Carbidopa – An underutilized, cost effective treatment of advanced Parkinson’s disease in the developing world
Objective: Advanced Parkinson’s disease manifests with “on-off” phenomenon, dyskinesias and increasing symptom severity . Managing it in developing countries is difficult given the low per…The Progressive Supranuclear Palsy Functional Disability Scale: Sensitivity to change
Objective: To determine the sensitivity to change within 12 months as well as completion time of the Progressive Supranuclear Palsy Functional Disability Scale (PSPFDS). Background:…Validation of the Movement Disorder Society criteria for the diagnosis of 4R-tauopathies
Objective: To validate the accuracy of the newly proposed Movement Disorder Society diagnostic criteria for progressive supranuclear palsy (MDS-PSP criteria, Höglinger et al., 2017) to…Stereopsis as a Visual Biomarker for Parkinson’s Disease
Objective: 1): To assess Parkinson’s disease (PD) patients’ stereopsis function using better and more physiologically meaningful tools; 2): To reveal specific eye behaviors of stereoacuity…Clinical and imaging characteristics of manifest LRRK2 and GBA carriers: The PPMI cohort
Objective: To compare baseline clinical and imaging characteristics of the GBA and LRRK2 PD manifest cohorts to PD sporadic (sPD) cohort. Background: The phenotype and…Successful treatment of Parkinson’s disease-related impulse control disorder with bilateral STN DBS
Objective: To present a case of Parkinson’s disease (PD) complicated by impulse control disorder (ICD) which improved following deep brain stimulation (DBS) targeting the bilateral…Impact of a high-fat diet on the behavior of A53T alpha-Synuclein Parkinson’s disease mice
Objective: The aim of this project was to evaluate high-fat diet (HFD) induced behavioral alterations in the A53T alpha-Synuclein Parkinsons’s disease mouse model. Background: Besides…MRI cortical layer study in patients with Parkinson’s disease in Uzbekistan
Objective: We aimed to establish, using MRI, the presence of differences in the thickness of the cortical layers in patients with early and developed stages…Heterogeneous patterns of striatal dopamine loss in patients with young- versus old-onset Parkinson’s disease
Objective: Patients with Parkinson's disease have different patterns of stiratal dopamine loss by age onf onset. Background: Ample evidence has suggested that age at onset…Discriminative power of different olfactory domains in Parkinson’s disease
Objective: The aim of this study was to evaluate which kind of olfactory domain was the best in discriminating PD patients from controls, and to…
- « Previous Page
- 1
- …
- 195
- 196
- 197
- 198
- 199
- …
- 217
- Next Page »